TrialStat Corporation (www.trialstat.com), a clinical data solutions on demand company, today announced that Khaled El Emam, the company’s Chief Scientist, will speak at the Adaptive Clinical Trial Designs conference in Toronto, Ontario on Wednesday, October 17.
Toronto, Ontario (PRWEB) October 15, 2007 -- TrialStat Corporation, a clinical data solutions on demand company, today announced that Khaled El Emam, the company’s Chief Scientist, will speak at the Adaptive Clinical Trial Designs conference in Toronto, Ontario on Wednesday, October 17. Mr. El Emam will discuss how electronic data capture (EDC) software can play a pivotal role in enabling clinical researchers to use adaptive clinical trial designs. The two-day conference examines strategic, regulatory and tactical implementation issues of adaptive clinical trial designs.
As a software as a service (SaaS) or on demand EDC solution, TrialStat’s ClinicalAnalytics 4.0™ (CA 4.0) enables organizations to deploy their studies up to two times faster than the industry average, which reduces the time, cost and risk associated with clinical research. CA 4.0 provides contract research organizations and biopharma organizations with an innovative EDC platform that enables the rapid deployment and management of adaptive clinical trial designs.
Details of the presentation are:
When: October 17 at 11:45am (EST)
Where: Adaptive Clinical Trial Designs Conference, Toronto, Ontario, Renaissance Hotel, Toronto, Ontario
What: Session II, Adaptive EDC: Critical Steps for Managing Adaptive Trials
TrialStat will demonstrate CA 4.0 at BOOTH 7. To request a copy of the presentation, please contact the TrialStat media representative below.
For media inquiries, please contact:
Muay Lim
TrialStat Corporation
613-741-9909 ext 153
www.trialstat.com
ClinicalAnalytics 4.0 is a trademark of TrialStat Corporation.
###
Trackback URL: http://www.prweb.com/pingpr.php/UGlnZy1TaW5nLVByb2YtVGhpci1UaGlyLVplcm8=
|
